| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| AMWLAmerican Well Corporation | 70.09M | 4.76 | -0.34 | -1.81% | -42.8% | -42.43% | 0.03 | |
| TDOCTeladoc Health, Inc. | 1.16B | 6.53 | -1.11 | -1.26% | -8.84% | -16.06% | 24.41% | 1.06 |
| EUDAEUDA Health Holdings Limited | 69.19M | 1.83 | -3.89 | 8.22% | 5.17% |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Sales/Revenue | 113.95M | 148.86M | 245.26M | 252.79M | 277.19M | 259.05M | 254.36M |
| Revenue Growth % | - | 0.31% | 0.65% | 0.03% | 0.1% | -0.07% | -0.02% |
| Cost of Goods Sold | 63.94M | 87.74M | 166.94M | 164.56M | 186.57M | 195.78M | 188.39M |
| COGS % of Revenue | 0.56% | 0.59% | 0.68% | 0.65% | 0.67% | 0.76% | 0.74% |
| Gross Profit | 50.01M | 61.12M | 78.32M | 88.23M | 90.61M | 63.27M | 65.98M |
| Gross Margin % | 0.44% | 0.41% | 0.32% | 0.35% | 0.33% | 0.24% | 0.26% |
| Gross Profit Growth % | - | 0.22% | 0.28% | 0.13% | 0.03% | -0.3% | 0.04% |
| Operating Expenses | 103.93M | 154.33M | 299.28M | 268.89M | 348.74M | 314.52M | 262.62M |
| OpEx % of Revenue | 0.91% | 1.04% | 1.22% | 1.06% | 1.26% | 1.21% | 1.03% |
| Selling, General & Admin | 67.66M | 100.39M | 214.87M | 162.29M | 210.25M | 208.69M | 176.55M |
| SG&A % of Revenue | 0.59% | 0.67% | 0.88% | 0.64% | 0.76% | 0.81% | 0.69% |
| Research & Development | 36.27M | 53.94M | 84.41M | 106.59M | 138.49M | 105.83M | 86.06M |
| R&D % of Revenue | 0.32% | 0.36% | 0.34% | 0.42% | 0.5% | 0.41% | 0.34% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -53.92M | -93.21M | -220.96M | -180.66M | -258.13M | -251.25M | -196.64M |
| Operating Margin % | -0.47% | -0.63% | -0.9% | -0.71% | -0.93% | -0.97% | -0.77% |
| Operating Income Growth % | - | -0.73% | -1.37% | 0.18% | -0.43% | 0.03% | 0.22% |
| EBITDA | -48.02M | -84.74M | -209.95M | -163.84M | -231.35M | -219.33M | -163.21M |
| EBITDA Margin % | -0.42% | -0.57% | -0.86% | -0.65% | -0.83% | -0.85% | -0.64% |
| EBITDA Growth % | - | -0.76% | -1.48% | 0.22% | -0.41% | 0.05% | 0.26% |
| D&A (Non-Cash Add-back) | 5.9M | 8.47M | 11.01M | 16.83M | 26.77M | 31.92M | 33.43M |
| EBIT | -52.31M | -89.17M | -225.8M | -179.03M | -269.73M | -672.72M | -206.78M |
| Net Interest Income | 2.79M | 5.54M | 1.63M | 120K | 6.12M | 19.42M | 10.76M |
| Interest Income | 2.79M | 5.54M | 1.63M | 120K | 6.12M | 19.42M | 10.76M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 1.61M | 4.04M | -7.03M | -1.5M | -13.88M | -424.06M | -13.24M |
| Pretax Income | -52.31M | -89.17M | -227.99M | -182.16M | -272.01M | -675.31M | -209.89M |
| Pretax Margin % | -0.46% | -0.6% | -0.93% | -0.72% | -0.98% | -2.61% | -0.83% |
| Income Tax | 0 | -803K | 639K | -5.38M | 64K | 3.86M | 2.75M |
| Effective Tax Rate % | 1.01% | 0.98% | 0.98% | 0.97% | 0.99% | 1% | 0.99% |
| Net Income | -52.67M | -87.19M | -224.43M | -176.33M | -270.43M | -675.16M | -208.14M |
| Net Margin % | -0.46% | -0.59% | -0.92% | -0.7% | -0.98% | -2.61% | -0.82% |
| Net Income Growth % | - | -0.66% | -1.57% | 0.21% | -0.53% | -1.5% | 0.69% |
| Net Income (Continuing) | -52.31M | -88.37M | -228.63M | -176.78M | -272.07M | -679.17M | -212.64M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 27.43M | 26.26M | 22.07M | 21.62M | 19.97M | 15.97M | 11.47M |
| EPS (Diluted) | -25.96 | -42.39 | -45.32 | -13.88 | -19.68 | -47.50 | -13.88 |
| EPS Growth % | - | -0.63% | -0.07% | 0.69% | -0.42% | -1.41% | 0.71% |
| EPS (Basic) | -25.96 | -42.39 | -45.32 | -13.88 | -19.68 | -47.50 | -13.88 |
| Diluted Shares Outstanding | 2.03M | 2.06M | 4.95M | 12.7M | 13.71M | 14.21M | 15M |
| Basic Shares Outstanding | 2.03M | 2.06M | 4.95M | 12.7M | 13.71M | 14.21M | 15M |
| Dividend Payout Ratio | - | - | - | - | - | - | - |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Total Current Assets | 300.17M | 223.53M | 1.11B | 827.3M | 626.62M | 449.58M | 316.99M |
| Cash & Short-Term Investments | 256.2M | 177.63M | 1.04B | 746.42M | 538.55M | 372.04M | 228.32M |
| Cash Only | 47.98M | 137.67M | 941.62M | 746.42M | 538.55M | 372.04M | 228.32M |
| Short-Term Investments | 208.23M | 39.95M | 99.96M | 0 | 0 | 0 | 0 |
| Accounts Receivable | 30.78M | 32.73M | 45.3M | 51.38M | 58.37M | 54.15M | 71.89M |
| Days Sales Outstanding | 98.58 | 80.25 | 67.41 | 74.18 | 76.86 | 76.29 | 103.15 |
| Inventory | 2.51M | 3.1M | 9.13M | 7.53M | 8.74M | 6.65M | 2.86M |
| Days Inventory Outstanding | 14.34 | 12.91 | 19.96 | 16.7 | 17.09 | 12.4 | 5.54 |
| Other Current Assets | 5.87M | 2.91M | 3.23M | 1.7M | 1.39M | 16.75M | 13.93M |
| Total Non-Current Assets | 189.15M | 276.35M | 263.36M | 618.54M | 590.94M | 140.12M | 118.97M |
| Property, Plant & Equipment | 3.08M | 14.61M | 10.45M | 18.66M | 14.52M | 11.03M | 7.58M |
| Fixed Asset Turnover | 37.03x | 10.19x | 23.48x | 13.55x | 19.09x | 23.50x | 33.56x |
| Goodwill | 127.27M | 193.88M | 193.88M | 442.76M | 435.28M | 0 | 0 |
| Intangible Assets | 55.39M | 63.53M | 55.53M | 152.41M | 134.98M | 120.25M | 101.54M |
| Long-Term Investments | 0 | 0 | 752K | 168K | 795K | 1.18M | 1.5M |
| Other Non-Current Assets | 4.5M | 5.48M | 1.43M | 2.52M | 6.16M | 7.67M | 8.36M |
| Total Assets | 489.31M | 499.88M | 1.38B | 1.45B | 1.22B | 589.71M | 435.97M |
| Asset Turnover | 0.23x | 0.30x | 0.18x | 0.17x | 0.23x | 0.44x | 0.58x |
| Asset Growth % | - | 0.02% | 1.75% | 0.05% | -0.16% | -0.52% | -0.26% |
| Total Current Liabilities | 87.83M | 106.58M | 120.98M | 141.63M | 114.06M | 93.8M | 111.26M |
| Accounts Payable | 4.23M | 6.5M | 5.8M | 12.16M | 7.24M | 4.86M | 5.01M |
| Days Payables Outstanding | 24.12 | 27.06 | 12.67 | 26.96 | 14.16 | 9.07 | 9.72 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 3.69M |
| Deferred Revenue (Current) | 1000K | 0 | 0 | 0 | 1000K | 1000K | 1000K |
| Other Current Liabilities | 8.3M | 66.49M | 66.69M | 83.84M | 35.97M | 12.14M | 23.34M |
| Current Ratio | 3.42x | 2.10x | 9.20x | 5.84x | 5.49x | 4.79x | 2.85x |
| Quick Ratio | 3.39x | 2.07x | 9.13x | 5.79x | 5.42x | 4.72x | 2.82x |
| Cash Conversion Cycle | 88.8 | 66.11 | 74.69 | 63.92 | 79.8 | 79.63 | 98.97 |
| Total Non-Current Liabilities | 605.89M | 18.37M | 9.47M | 43.34M | 19.65M | 15.72M | 8.46M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 7.16M | 1.3M | 14.69M | 11.79M | 8.21M | 4.51M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 576.72M | 11.21M | 64K | 21.59M | 1.57M | 1.43M | 1.17M |
| Total Liabilities | 693.72M | 124.95M | 130.45M | 184.96M | 133.71M | 109.52M | 119.72M |
| Total Debt | 0 | 13.4M | 7.65M | 16.61M | 14.84M | 11.79M | 8.2M |
| Net Debt | -47.98M | -124.28M | -933.96M | -729.8M | -523.7M | -360.25M | -220.12M |
| Debt / Equity | - | 0.04x | 0.01x | 0.01x | 0.01x | 0.02x | 0.03x |
| Debt / EBITDA | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - |
| Total Equity | 371.3M | 374.94M | 1.25B | 1.26B | 1.08B | 480.19M | 316.24M |
| Equity Growth % | - | 0.01% | 2.32% | 0.01% | -0.14% | -0.56% | -0.34% |
| Book Value per Share | 182.98 | 182.28 | 251.64 | 99.25 | 79.04 | 33.79 | 21.08 |
| Total Shareholders' Equity | 343.87M | 348.68M | 1.22B | 1.24B | 1.06B | 464.22M | 304.77M |
| Common Stock | 49K | 423K | 2.36M | 2.62M | 2.77M | 2.88M | 156K |
| Retained Earnings | -270.74M | -357.93M | -582.36M | -811.28M | -1.08B | -1.76B | -1.97B |
| Treasury Stock | 0 | -158K | -37.57M | 0 | 0 | 0 | 0 |
| Accumulated OCI | 1.35M | 250K | 297K | -6.35M | -16.97M | -15.65M | -15.84M |
| Minority Interest | 27.43M | 26.26M | 22.07M | 21.62M | 19.97M | 15.97M | 11.47M |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Cash from Operations | -74.01M | -81.89M | -112.46M | -141.54M | -192.32M | -148.34M | -127.34M |
| Operating CF Margin % | -0.65% | -0.55% | -0.46% | -0.56% | -0.69% | -0.57% | -0.5% |
| Operating CF Growth % | - | -0.11% | -0.37% | -0.26% | -0.36% | 0.23% | 0.14% |
| Net Income | -52.31M | -88.37M | -228.63M | -176.78M | -272.07M | -675.16M | -208.14M |
| Depreciation & Amortization | 5.33M | 7.76M | 10.15M | 16.09M | 26.17M | 31.92M | 33.43M |
| Stock-Based Compensation | 7.67M | 12.13M | 118.36M | 43.81M | 67.67M | 72.25M | 0 |
| Deferred Taxes | 884K | -1.39M | 3.83M | -6.25M | -2.52M | -242K | -243K |
| Other Non-Cash Items | 1.19M | 2.49M | 2.26M | 9.31M | 16.53M | 438.4M | 57.59M |
| Working Capital Changes | -36.77M | -14.52M | -18.45M | -27.71M | -28.1M | -15.51M | -9.98M |
| Change in Receivables | -19.47M | 803K | -14.21M | -512K | -8.14M | 3.25M | -25.01M |
| Change in Inventory | 1.57M | -592K | -6.02M | 1.6M | -1.21M | 2.08M | 1.9M |
| Change in Payables | -787K | 1.16M | -707K | 5.55M | -4.78M | -2.36M | 159K |
| Cash from Investing | -245.93M | 120M | -66.76M | -59.63M | -11.63M | -19.17M | -18.65M |
| Capital Expenditures | -1.91M | -1.34M | -3.32M | -559K | -10.45M | -292K | 0 |
| CapEx % of Revenue | 0.02% | 0.01% | 0.01% | 0% | 0.04% | 0% | 0.06% |
| Acquisitions | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | -2.55M | 0 | -18.88M | -18.65M |
| Cash from Financing | 278.18M | 46.64M | 983.12M | 5.75M | -3.61M | 2.15M | 1.38M |
| Debt Issued (Net) | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - |
| Other Financing | 635K | 1.04M | 2.64M | 20.79M | -3.25M | 2.73M | 1.38M |
| Net Change in Cash | - | - | - | - | - | - | - |
| Free Cash Flow | -75.92M | -83.23M | -115.78M | -142.1M | -202.77M | -163.59M | -142.56M |
| FCF Margin % | -0.67% | -0.56% | -0.47% | -0.56% | -0.73% | -0.63% | -0.56% |
| FCF Growth % | - | -0.1% | -0.39% | -0.23% | -0.43% | 0.19% | 0.13% |
| FCF per Share | -37.41 | -40.46 | -23.38 | -11.19 | -14.79 | -11.51 | -9.50 |
| FCF Conversion (FCF/Net Income) | 1.40x | 0.94x | 0.50x | 0.80x | 0.71x | 0.22x | 0.61x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 193K | 713K | 1.59M | 1.72M | 5M | 4.11M |
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -14.19% | -23.37% | -27.69% | -14.07% | -23.07% | -86.34% | -52.27% |
| Return on Invested Capital (ROIC) | - | -24.36% | -58.88% | -32.13% | -35.48% | -55.42% | -136.52% |
| Gross Margin | 43.89% | 41.06% | 31.93% | 34.9% | 32.69% | 24.42% | 25.94% |
| Net Margin | -46.22% | -58.57% | -91.51% | -69.76% | -97.56% | -260.63% | -81.83% |
| Debt / Equity | - | 0.04x | 0.01x | 0.01x | 0.01x | 0.02x | 0.03x |
| FCF Conversion | 1.40x | 0.94x | 0.50x | 0.80x | 0.71x | 0.22x | 0.61x |
| Revenue Growth | - | 30.63% | 64.77% | 3.07% | 9.65% | -6.55% | -1.81% |
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Visits | 117.18M | 116.62M | 124.35M | 119.48M | 116.46M |
| Visits Growth | - | -0.48% | 6.63% | -3.91% | -2.54% |
| Platform Subscription | 98.36M | 108.25M | 120.92M | 112.36M | 115.54M |
| Platform Subscription Growth | - | 10.06% | 11.70% | -7.08% | 2.83% |
| Others | 29.72M | 27.92M | 31.92M | 27.2M | 22.36M |
| Others Growth | - | -6.07% | 14.34% | -14.79% | -17.78% |
American Well Corporation (AMWL) reported $265.0M in revenue for fiscal year 2024. This represents a 133% increase from $114.0M in 2018.
American Well Corporation (AMWL) saw revenue decline by 1.8% over the past year.
American Well Corporation (AMWL) reported a net loss of $113.4M for fiscal year 2024.
American Well Corporation (AMWL) has a return on equity (ROE) of -52.3%. Negative ROE indicates the company is unprofitable.
American Well Corporation (AMWL) had negative free cash flow of $64.5M in fiscal year 2024, likely due to heavy capital investments.